NCT01549743View on ClinicalTrials.gov

The Pharmacokinetic Interaction Between Celecoxib and Rebamipide

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 9, 2012

Primary Completion Date

June 13, 2012

Study Completion Date

June 13, 2012

Conditions
Healthy Male Volunteers
Interventions
DRUG

Celecoxib

Celecoxib 200mg will be administered orally twice a day for 3 days

DRUG

Rebamipide

Rebamipide 100mg will be administered orally three times a day for 3 days

DRUG

Celecoxib plus Rebamipide

"Celecoxib plus Rebamipide same way as arm: celecoxib and arm: rebamipide"

Trial Locations (1)

136-705

The Korea Univertisy Anam Hospital, Seoul

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT01549743 - The Pharmacokinetic Interaction Between Celecoxib and Rebamipide | Biotech Hunter | Biotech Hunter